Shots:

• mAbxience will equip their state-of-the-art cGMP facility in Spain with an ABEC 4-000L CSR Bioreactor
• The system will be commissioned mid-2021 and will increase biosimilar and CDMO manufacturing capacity at the León site
• The 4-000L volume & performance comparable to stainless steel systems will enable mAbxience to improve flexibility- productivity and efficiency. The CSR bioreactor design also allows for seamless scale-up and transfer of cell culture processes- thereby reducing time to market for mAbxience’s products

  Ref: Businesswire | Image: mAbxience